This protocol addresses the clinical scenario in which oral nicotinamide (niacinamide) supplementation was used for Vitamin B3 deficiency but the expected early response — including subsidence of skin lesions — was not achieved. A structured next-step approach is available for this situation.
The previous treatment line involved oral nicotinamide (niacinamide) supplementation together with other group B vitamins and photoprotection measures. Escalation to this protocol is indicated when the anticipated early clinical improvement — in particular, subsidence of skin lesions — was not achieved within the expected response window.
The next-step protocol involves an alternative vitamin B3 compound used under specific circumstances. The complete regimen — including selection criteria, accompanying measures, and clinical guidance — is set out in the full structured protocol.
DOI: 10.24425/fmc.2021.138956
View source ↗